Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data MARCHEX INC files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
130
90.3
85.3
54.5
51.2
53.5
52.2
49.9
48.1
45.4
Cost of revenue
77
49.3
47.8
18
20.9
21.7
20.5
20.6
17.2
16.7
Gross profit
52.6
41
37.4
36.5
30.3
31.8
31.7
29.3
31
28.7
Research and development
28.4
18.1
15.4
17.9
21
16.1
14.4
15.4
12.4
9.75
Selling and marketing
22.3
15.7
13.8
13.7
16.7
13.5
13.5
11.4
12.1
12.5
General and administrative
21.8
13.6
10.9
13
12.8
9.29
9.79
10.2
10.2
10.8
Operating income
-83.9
-6.36
-3.89
-14
-44.1
-11.8
-8.15
-9.64
-4.45
-5.72
Interest expense
0.11
0.03
0.04
0.28
Interest income
0.07
Other non-operating income
-0.12
0.32
Pre-tax income
-84
-6.05
-2.83
-13.2
-43.9
-4.16
-8.06
-9.82
-4.57
-5.16
Income tax
0.05
0.04
-0.16
-3.48
-1.92
0.23
0.18
0.09
0.38
0.08
Income from continuing operations
-84.1
-6.09
Net income
-84.1
-6.09
-2.68
-4.04
-38.4
-4.39
-8.25
-9.91
-4.95
-5.24
EBITDA
-80.7
-3.56
-2.39
-12.5
-42.5
-10.6
-6.55
-7.86
-3.05
-4.37
EPS, basic
-2.01
-0.10
-0.19
-0.23
-0.11
-0.12
EPS, diluted
-2.01
-0.10
-0.19
-0.23
-0.11
-0.12
Dividend per share
0.50
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
104
104
45.2
41.7
33.9
27.1
20.5
14.6
12.8
9.94
Receivables
18.9
14.9
16.2
7.53
6.33
8.02
8.4
7.39
7.07
6.67
Other current assets
1.63
2.04
2.66
2.02
2.16
2.41
2.02
1.81
1.74
1.42
Total current assets
125
121
64.1
62.4
42.3
37.5
30.9
23.8
22.3
19
Property, plant and equipment
3.56
2.41
2.92
3
2.75
2.82
4.05
2.4
1.81
1.85
Lease right-of-use assets
5.8
3.74
2.24
0.74
1.63
1.16
0.67
Goodwill
0
0
24.4
32.3
17.6
17.6
17.6
17.6
17.6
17.6
Intangible assets
20.7
19.5
9.2
4.71
2.59
0.6
0
Other non-current assets
0.21
0.33
0.92
0.31
1.35
0.99
0.97
1.48
0.4
0.56
Total assets
128
124
113
125
76.9
65.8
56.8
47.5
43.2
39.7
Accounts payable
6.81
4.93
5.97
0.62
2.42
1.36
2.04
1.53
1.35
3.2
Deferred revenue
0.35
0.31
1.78
0.87
1.39
2.02
1.38
1.21
1.09
0.6
Short-term debt
5.12
0.8
Total current liabilities
14.9
32.7
14.8
17.5
21
12.7
12.1
9.72
9.27
8.07
Lease liabilities
5.66
3.14
1.47
0.39
1.22
0.72
0.37
Other non-current liabilities
0.13
1.09
1.29
0.47
0.5
Total liabilities
15
33.8
18
24.7
24.2
14.3
12.7
11.6
10.6
9.6
Total debt
5.12
Paid-in capital
360
343
351
360
351
354
355
357
358
361
Retained earnings
-248
-254
-256
-260
-299
-303
-311
-321
-326
-331
Shareholders' equity
113
90
95
99.8
52.7
51.5
44.1
35.9
32.6
30.1
Total equity
113
90
95
99.8
52.7
51.5
44.1
35.9
32.6
30.1
Total liabilities and equity
128
124
113
125
76.9
65.8
56.8
47.5
43.2
39.7
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-84.1
-6.09
-2.68
-4.04
-38.4
-4.39
-8.25
-9.91
-4.95
-5.24
Depreciation and amortization
3.2
2.8
1.5
1.5
1.6
1.2
1.6
1.78
1.4
1.35
Stock-based compensation
10.2
4.6
3.04
3.15
3.83
2.67
2.65
2.39
1.71
2.39
Deferred income tax
-0.19
-1.73
-0.83
-0.01
0.04
0.33
0.09
Change in receivables
4.02
3.84
0.25
0.04
-0.08
-2.13
-1.28
0.36
0.47
0.31
Change in payables
-2.61
-1.96
0.62
-0.22
1.79
-1.05
0.68
-1.26
-0.57
1.85
Cash from operations
-3.67
1.69
5.05
5.09
-3.37
-6.34
-2.29
-4.4
-1.1
-1.41
Capital expenditures
-0.99
-1.56
-1.65
-1.62
-1.35
-1.35
-2.87
-1.38
-0.38
-0.04
Acquisitions
-34.3
-7.92
0.09
Cash from investing
-1.22
-1.58
-36.6
-9.68
0.98
-0.95
-2.87
-1.31
-0.43
-1.32
Stock issued
0.24
0.09
0.09
0
0
0.45
0
Share buybacks
-0.37
-5.67
-10.9
Dividends paid
-21.9
Cash from financing
-0.31
0.13
-27.4
1.89
-5.49
0.53
-1.46
-0.16
-0.31
-0.1
Net change in cash
-5.21
0.24
-59
-2.7
-7.88
-6.77
-6.61
-5.87
-1.84
-2.83
Free cash flow
-4.66
0.13
3.4
3.47
-4.73
-7.69
-5.16
-5.77
-1.49
-1.44
Interest paid
0.04
0.12
0.12
0.08
Income taxes paid
-0.02
0.02
-0.05
0.03
-0.04
-0.17
0.06
0.07
0.06
0.05
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.31 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
61.2%
Gross profit / revenue.
Operating margin
-11.4%
Operating income / revenue.
EBITDA margin
-8.6%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-11.8%
Pre-tax income / revenue.
Net margin
-12.4%
Net income / revenue.
Operating cash flow margin
-1.7%
Cash from operations / revenue.
Return on equity (ROE)
-18.8%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-14.5%
Net income / average total assets.
Return on invested capital (ROIC)
-19.0%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
20.4%
Research and development expense / revenue.
Stock-based pay / revenue
5.4%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
2.8%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-5.6%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-4.5%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-2.4%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-7.3%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-3.3%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-1.1%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-7.8%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-12.0%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-10.6%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-8.1%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-11.3%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-12.4%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.29x
Current assets / current liabilities.
Quick ratio
2.00x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.07x
(Cash + short-term investments) / current liabilities.
Market cap + total debt - cash - short-term investments.
P/S
1.32x
Market cap / revenue.
P/B
2.00x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
5.06x
Market cap / tangible book value, when positive.
EV/Sales
1.14x
Enterprise value / revenue.
Earnings yield
-9.4%
Net income / market cap (the inverse of P/E).
What was MARCHEX INC's revenue in fiscal 2025?
MARCHEX INC reported revenue of $45.4M for fiscal 2025, 5.6% lower than the year before.
Was MARCHEX INC profitable in fiscal 2025?
No. It reported a net loss of $5.2M.
How much free cash flow did MARCHEX INC generate in fiscal 2025?
Cash from operations of $1.4M minus capital expenditures of $36.0K left free cash flow of -$1.4M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.